Phase 1 Clinical Study of JTS-661 - Pharmacokinetic Study in Patients on Hemodialysis
Phase 1
- Conditions
- Japanese patients with CKD on maintenance hemodialysis
- Registration Number
- JPRN-jRCT2080223686
- Lead Sponsor
- JAPAN TABACCO INC.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Japanese patients aged 20 to 80 years (inclusive) at consent; however, female subjects must be postmenopausal
- Patients on hemodialysis (including hemodiafiltration) three times a week for at least 12 weeks before the screening visit
- Outpatients
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method